Accession | ARO:3004153 |
Synonym(s) | Rv2764c |
CARD Short Name | Mtub_thyA_PAS |
Definition | Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance. |
AMR Gene Family | aminosalicylate resistant thymidylate synthase |
Drug Class | salicylic acid antibiotic |
Resistance Mechanism | antibiotic target alteration |
Resistomes with Sequence Variants | Mycobacterium tuberculosisg+wgs |
Classification | 8 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + antibiotic target alteration [Resistance Mechanism] + mutation conferring antibiotic resistance + determinant of antibiotic resistance + antibiotic molecule + salicylic acid antibiotic [Drug Class] + antibiotic resistant gene variant or mutant |
Parent Term(s) | 2 ontology terms | Show + confers_resistance_to_antibiotic para-aminosalicylic acid [Antibiotic] + aminosalicylate resistant thymidylate synthase [AMR Gene Family] |
Publications | Zhang X, et al. 2015. Antimicrob. Agents Chemother. 59(2):1320-4 Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012. (PMID 25421465) |
Prevalence of Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid among the sequenced genomes, plasmids, and whole-genome shotgun assemblies available at NCBI or IslandViewer for 413 important pathogens (see methodological details and complete list of analyzed pathogens). Values reflect percentage of genomes, plasmids, genome islands, or whole-genome shotgun assemblies that have at least one hit to the AMR detection model. Default view includes percentages calculated based on Perfect plus Strict RGI hits. Select the checkbox to view percentages based on only Perfect matches to AMR reference sequences curated in CARD (note: this excludes resistance via mutation as references in protein variant models are often wild-type, sensitive sequences).
Species | NCBI Chromosome | NCBI Plasmid | NCBI WGS | NCBI GI |
---|---|---|---|---|
Mycobacterium tuberculosis | 14.96% | 0% | 22.61% | 0% |
Model Type: protein variant model
Model Definition: Protein Variant Models (PVM) perform a similar search as Protein Homolog Models (PHM), i.e. detect protein sequences based on their similarity to a curated reference sequence, but secondarily screen query sequences for curated sets of mutations to differentiate them from antibiotic susceptible wild-type alleles. PVMs are designed to detect AMR acquired via mutation of house-keeping genes or antibiotic targets, e.g. a mutated gyrase resistant to aminocoumarin antibiotics. PVMs include a protein reference sequence (often from antibiotic susceptible wild-type alleles), a curated bit-score cut-off, and mapped resistance variants. Mapped resistance variants may include any or all of single point mutations, insertions, or deletions curated from the scientific literature. A Strict RGI match has a BLASTP bit-score above the curated BLASTP cutoff value and contains at least one curated mutation from amongst the mapped resistance variants, while a Loose RGI match has a bit-score less than the curated BLASTP bit-score cut-off but still contains at least one curated mutation from amongst the mapped resistance variants.
Bit-score Cut-off (blastP): 500
Type of Antibiotic Resistance: Intrinsic or chromosomally-encoded
Legend:
Published Variants:
PMID: 25421465 | T22A Y36C H75N V77F W83C G91R W101R S105P R126Q F152V C161T T202A H207R I211V P224L R235P G76STOP W83STOP W98STOP -nt111:T +nt217:CACGAGCAC -nt260:C +nt372:T -nt472:C |